Cargando…
Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study
BACKGROUND: The post-acute burden of health care use after SARS-CoV-2 infection is unknown. We sought to quantify the post-acute burden of health care use after SARS-CoV-2 infection among community-dwelling adults in Ontario by comparing those with positive and negative polymerase chain reaction (PC...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
CMA Impact Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616149/ https://www.ncbi.nlm.nih.gov/pubmed/36252983 http://dx.doi.org/10.1503/cmaj.220728 |
_version_ | 1784820587569348608 |
---|---|
author | McNaughton, Candace D. Austin, Peter C. Sivaswamy, Atul Fang, Jiming Abdel-Qadir, Husam Daneman, Nick Udell, Jacob A. Wodchis, Walter P. Mostarac, Ivona Lee, Douglas S. Atzema, Clare L. |
author_facet | McNaughton, Candace D. Austin, Peter C. Sivaswamy, Atul Fang, Jiming Abdel-Qadir, Husam Daneman, Nick Udell, Jacob A. Wodchis, Walter P. Mostarac, Ivona Lee, Douglas S. Atzema, Clare L. |
author_sort | McNaughton, Candace D. |
collection | PubMed |
description | BACKGROUND: The post-acute burden of health care use after SARS-CoV-2 infection is unknown. We sought to quantify the post-acute burden of health care use after SARS-CoV-2 infection among community-dwelling adults in Ontario by comparing those with positive and negative polymerase chain reaction (PCR) test results for SARS-CoV-2 infection. METHODS: We conducted a retrospective cohort study involving community-dwelling adults in Ontario who had a PCR test between Jan. 1, 2020, and Mar. 31, 2021. Follow-up began 56 days after PCR testing. We matched people 1:1 on a comprehensive propensity score. We compared per-person-year rates for health care encounters at the mean and 99th percentiles, and compared counts using negative binomial models, stratified by sex. RESULTS: Among 531 702 matched people, mean age was 44 (standard deviation [SD] 17) years and 51% were female. Females who tested positive for SARS-CoV-2 had a mean of 1.98 (95% CI 1.63 to 2.29) more health care encounters overall per-person-year than those who had a negative test result, with 0.31 (95% CI 0.05 to 0.56) more home care encounters to 0.81 (95% CI 0.69 to 0.93) more long-term care days. At the 99th percentile per-person-year, females who tested positive had 6.48 more days of hospital admission and 28.37 more home care encounters. Males who tested positive for SARS-CoV-2 had 0.66 (95% CI 0.34 to 0.99) more overall health care encounters per-person-year than those who tested negative, with 0.14 (95% CI 0.06 to 0.21) more outpatient encounters and 0.48 (95% CI 0.36 to 0.60) long-term care days, and 0.43 (95% CI −0.67 to −0.21) fewer home care encounters. At the 99th percentile, they had 8.69 more days in hospital per-person-year, with fewer home care (−27.31) and outpatient (−0.87) encounters. INTERPRETATION: We found significantly higher rates of health care use after a positive SARS-CoV-2 PCR test in an analysis that matched test-positive with test-negative people. Stakeholders can use these findings to prepare for health care demand associated with post-COVID-19 condition (long COVID). |
format | Online Article Text |
id | pubmed-9616149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | CMA Impact Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96161492022-10-29 Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study McNaughton, Candace D. Austin, Peter C. Sivaswamy, Atul Fang, Jiming Abdel-Qadir, Husam Daneman, Nick Udell, Jacob A. Wodchis, Walter P. Mostarac, Ivona Lee, Douglas S. Atzema, Clare L. CMAJ Research BACKGROUND: The post-acute burden of health care use after SARS-CoV-2 infection is unknown. We sought to quantify the post-acute burden of health care use after SARS-CoV-2 infection among community-dwelling adults in Ontario by comparing those with positive and negative polymerase chain reaction (PCR) test results for SARS-CoV-2 infection. METHODS: We conducted a retrospective cohort study involving community-dwelling adults in Ontario who had a PCR test between Jan. 1, 2020, and Mar. 31, 2021. Follow-up began 56 days after PCR testing. We matched people 1:1 on a comprehensive propensity score. We compared per-person-year rates for health care encounters at the mean and 99th percentiles, and compared counts using negative binomial models, stratified by sex. RESULTS: Among 531 702 matched people, mean age was 44 (standard deviation [SD] 17) years and 51% were female. Females who tested positive for SARS-CoV-2 had a mean of 1.98 (95% CI 1.63 to 2.29) more health care encounters overall per-person-year than those who had a negative test result, with 0.31 (95% CI 0.05 to 0.56) more home care encounters to 0.81 (95% CI 0.69 to 0.93) more long-term care days. At the 99th percentile per-person-year, females who tested positive had 6.48 more days of hospital admission and 28.37 more home care encounters. Males who tested positive for SARS-CoV-2 had 0.66 (95% CI 0.34 to 0.99) more overall health care encounters per-person-year than those who tested negative, with 0.14 (95% CI 0.06 to 0.21) more outpatient encounters and 0.48 (95% CI 0.36 to 0.60) long-term care days, and 0.43 (95% CI −0.67 to −0.21) fewer home care encounters. At the 99th percentile, they had 8.69 more days in hospital per-person-year, with fewer home care (−27.31) and outpatient (−0.87) encounters. INTERPRETATION: We found significantly higher rates of health care use after a positive SARS-CoV-2 PCR test in an analysis that matched test-positive with test-negative people. Stakeholders can use these findings to prepare for health care demand associated with post-COVID-19 condition (long COVID). CMA Impact Inc. 2022-10-17 2022-10-17 /pmc/articles/PMC9616149/ /pubmed/36252983 http://dx.doi.org/10.1503/cmaj.220728 Text en © 2022 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Research McNaughton, Candace D. Austin, Peter C. Sivaswamy, Atul Fang, Jiming Abdel-Qadir, Husam Daneman, Nick Udell, Jacob A. Wodchis, Walter P. Mostarac, Ivona Lee, Douglas S. Atzema, Clare L. Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study |
title | Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study |
title_full | Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study |
title_fullStr | Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study |
title_full_unstemmed | Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study |
title_short | Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study |
title_sort | post-acute health care burden after sars-cov-2 infection: a retrospective cohort study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616149/ https://www.ncbi.nlm.nih.gov/pubmed/36252983 http://dx.doi.org/10.1503/cmaj.220728 |
work_keys_str_mv | AT mcnaughtoncandaced postacutehealthcareburdenaftersarscov2infectionaretrospectivecohortstudy AT austinpeterc postacutehealthcareburdenaftersarscov2infectionaretrospectivecohortstudy AT sivaswamyatul postacutehealthcareburdenaftersarscov2infectionaretrospectivecohortstudy AT fangjiming postacutehealthcareburdenaftersarscov2infectionaretrospectivecohortstudy AT abdelqadirhusam postacutehealthcareburdenaftersarscov2infectionaretrospectivecohortstudy AT danemannick postacutehealthcareburdenaftersarscov2infectionaretrospectivecohortstudy AT udelljacoba postacutehealthcareburdenaftersarscov2infectionaretrospectivecohortstudy AT wodchiswalterp postacutehealthcareburdenaftersarscov2infectionaretrospectivecohortstudy AT mostaracivona postacutehealthcareburdenaftersarscov2infectionaretrospectivecohortstudy AT leedouglass postacutehealthcareburdenaftersarscov2infectionaretrospectivecohortstudy AT atzemaclarel postacutehealthcareburdenaftersarscov2infectionaretrospectivecohortstudy |